MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.